The combination of PDT and STING agonists has been shown to strongly augment the efficacy of antitumor therapy, so local delivery of photosensitizers and STING agonists based on nanoplatforms is expected to maximize tumor elimination (Ding et al., 2024). This evidence concerns the gene STING1 and neoplasm.